Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study

Table 4 Percentages of patients with chronic pain (mITT population)

	Chronic pain	Mirogabalin add-on group (N = 63)	Conventional treatment group (N = 65)	Fisher P value^a
Week 8	No	41 (65.1)	35 (53.8)	0.113
	Yes	9 (14.3)	17 (26.2)
	No test	13 (20.6)	13 (20.0)
Week 12	No	44 (69.8)	39 (60.0)	0.171
	Yes	5 (7.9)	11 (16.9)
	No test	14 (22.2)	15 (23.1)

ISSN: 1471-2407